NO752525L - - Google Patents
Info
- Publication number
- NO752525L NO752525L NO752525A NO752525A NO752525L NO 752525 L NO752525 L NO 752525L NO 752525 A NO752525 A NO 752525A NO 752525 A NO752525 A NO 752525A NO 752525 L NO752525 L NO 752525L
- Authority
- NO
- Norway
- Prior art keywords
- cercariae
- worms
- meta
- infection
- host
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 10
- 208000006275 fascioliasis Diseases 0.000 claims description 7
- 201000004409 schistosomiasis Diseases 0.000 claims description 6
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 241000754688 Cercaria Species 0.000 claims description 4
- 230000001900 immune effect Effects 0.000 claims description 4
- 230000004614 tumor growth Effects 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 230000001024 immunotherapeutic effect Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 description 24
- 239000000243 solution Substances 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- 235000013601 eggs Nutrition 0.000 description 10
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000011887 Necropsy Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000242678 Schistosoma Species 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001524 infective effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000017448 oviposition Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 241000242711 Fasciola hepatica Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241001491880 Heterophyes Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000019526 Schistosoma mansoni infectious disease Diseases 0.000 description 1
- 208000002848 Schistosomiasis mansoni Diseases 0.000 description 1
- 241000256251 Spodoptera frugiperda Species 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7409359A SE7409359L (sv) | 1974-07-17 | 1974-07-17 | Immunologisk och immunoterapeutisk kontroll av schistosomiasisinfektion och tumortillvext med kemiskt forbehandlade cerkarier. |
| SE7409589A SE7409589L (sv) | 1974-07-23 | 1974-07-23 | Immunologisk och immunoterapeutisk kontroll av fascioliasisinfektion genom: a)extrakt fran kemiskt forbehandlade sniglar av lymnae-typ eller b)kemiskt forbehandlade metacerkarier. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO752525L true NO752525L (en:Method) | 1976-01-20 |
Family
ID=26656508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO752525A NO752525L (en:Method) | 1974-07-17 | 1975-07-15 |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5135416A (en:Method) |
| DE (1) | DE2530090A1 (en:Method) |
| DK (1) | DK323975A (en:Method) |
| FI (1) | FI752064A7 (en:Method) |
| FR (1) | FR2278346A1 (en:Method) |
| LU (1) | LU73006A1 (en:Method) |
| NL (1) | NL7508588A (en:Method) |
| NO (1) | NO752525L (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61141196A (ja) * | 1984-12-13 | 1986-06-28 | 神東塗料株式会社 | 微細な導電性パターンを有する基体の選択接着方法 |
-
1975
- 1975-07-05 DE DE19752530090 patent/DE2530090A1/de active Pending
- 1975-07-15 NO NO752525A patent/NO752525L/no unknown
- 1975-07-16 FR FR7522187A patent/FR2278346A1/fr not_active Withdrawn
- 1975-07-16 FI FI752064A patent/FI752064A7/fi not_active Application Discontinuation
- 1975-07-16 DK DK323975A patent/DK323975A/da unknown
- 1975-07-17 LU LU73006A patent/LU73006A1/xx unknown
- 1975-07-17 NL NL7508588A patent/NL7508588A/xx unknown
- 1975-07-17 JP JP50086733A patent/JPS5135416A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5135416A (en) | 1976-03-25 |
| DE2530090A1 (de) | 1976-01-29 |
| LU73006A1 (en:Method) | 1976-07-01 |
| FR2278346A1 (fr) | 1976-02-13 |
| FI752064A7 (en:Method) | 1976-01-18 |
| NL7508588A (nl) | 1976-01-20 |
| DK323975A (da) | 1976-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2900258A2 (en) | Subunit immersion vaccines for fish | |
| CN112500458A (zh) | 鸡传染性法氏囊病病毒新型变异株亚单位疫苗、其制备方法及应用 | |
| Vedi et al. | Vaccination with 73 kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models | |
| RU2018123005A (ru) | Способы лечения, предотвращения и диагностики вирусной инфекции эпидемической диареи свиней | |
| CN108003240B (zh) | 一种海水养殖鱼多联抗独特型卵黄抗体疫苗及其制备方法 | |
| Calnek et al. | Rejection of a transplantable Marek's disease lymphoma in normal versus immunologically deficient chickens | |
| Adams | A preliminary evaluation of factors affecting an experimental system for vaccination-and-challenge with Haemonchus contortus in sheep | |
| Bickle et al. | Resistance following drug attenuation (Ro 11–3128 or oxamniquine) of early Schistosoma mansoni infections in mice | |
| KR100267747B1 (ko) | 돼지 대장균 및 유행성 설사바이러스에 의한 설사증 예방 및치료용 난황항체를 이용한 복합 면역제제 | |
| Hope et al. | A biological and immunological comparison of Chinese and Philippine Schistosoma japonicum | |
| NO752525L (en:Method) | ||
| CN106967174B (zh) | 多肽融合蛋白gwp在抗立氏立克次体的免疫保护中的应用 | |
| Wedrychowicz et al. | Immune responses of sheep to surface antigens of infective larvae of Ostertagia circumcincta | |
| Mazza et al. | Antibody isotype responses to the Schistosoma mansoni schistosomulum in the CBA/N mouse induced by different stages of the parasite life cycle | |
| Dean et al. | Homologous and heterologous protective immunity to Egyptian strains of Schistosoma mansoni and S. haematobium induced by ultraviolet‐irradiated cercariae | |
| CN109438575A (zh) | 一种大口黑鲈弹状病毒卵黄抗体 | |
| EP0037441B1 (en) | Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein | |
| Charney et al. | Immunization studies with mammary tumor virus | |
| Kornblum | The application of the irradiated hamster test to the study of experimental allergic encephalomyelitis | |
| US3769400A (en) | Process for the manufacture of a live vaccine against the infectious bursitis of chickens | |
| CN115322971A (zh) | 一种鱼类圆环病毒及应用 | |
| HUE029385T2 (en) | Marker vaccine for classical swine fever | |
| CN107653231A (zh) | 鸭源性冠状病毒弱毒株ibvdcv35及其应用 | |
| CN101759774A (zh) | 一种抗猪圆环病病毒转移因子的制备方法 | |
| Baldwin et al. | Isolation of membrane-associated tumour-specific antigens from rat hepatomas induced by aminoazo dye |